FDA OKs First Adaptive DBS System for Parkinson’s Disease

The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity in real time.  Medtronic’s BrainSense aDBS system is currently for use in patients with PD who have been implanted with the Medtronic Percept neurostimulator. …